HIMS & HERS HEALTH (NYSE: HIMS) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By August 25, 2025

Core Viewpoint - Berger Montague is investigating potential securities fraud claims against Hims & Hers Health Inc. for making false or misleading statements to investors during the Class Period from April 29, 2025, to June 22, 2025 [1][2] Securities Fraud Investigation Details - On June 23, 2025, Hims & Hers shares fell over 34% after Novo Nordisk terminated its partnership due to unauthorized marketing and sale of compounded semaglutide drugs [2] - A complaint has been filed alleging material misstatements and omissions in violation of federal securities laws [2] Deadline to Act - Investors have until August 25, 2025, to seek appointment as lead plaintiff in the class action lawsuit [3] - Lead plaintiffs will help direct the case and advocate on behalf of other harmed investors [3]